Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Turcot syndrome 1Lymphatic Metastasis 1

Interventions

Specimen Handling 22Magnetic Resonance Spectroscopy 20Carboplatin 17Gemcitabine 15pembrolizumab 13Cisplatin 13Paclitaxel 12Injections 11Interviews as Topic 10fludarabine 9Radiotherapy 9Cyclophosphamide 9Oxaliplatin 8Dexamethasone 8Biopsy 8Bevacizumab 8toripalimab 7Nivolumab 7Irinotecan 7Fluorouracil 7Bortezomib 7X-Rays 6Radiosurgery 6Pemetrexed 6Leucovorin 6Capecitabine 6durvalumab 5cemiplimab 5anlotinib 5Doxorubicin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × DNA Mismatch Repair × 30 days × Clear all
NCT07625735 2026-06-04

MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastric Cancer

Shanghai Zhongshan Hospital

Not yet recruiting
3,000 enrolled

Turcot syndrome, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡